Selected research
Industry Growth & Trends
Global Medical Device Software Validation Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Medical Device Software Validation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Medical Device Software Validation market include QbD Group, Intertek, SGS, QuEST, TÜV SÜD AG, NAMSA, Element, Eurofins Scientific and Charles River, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Medical Device Software Validation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Medical Device Software Validation market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Device Software Validation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Device Software Validation.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Medical Device Software Validation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Medical Device Software Validation Market by Company
QbD Group
Intertek
SGS
QuEST
TÜV SÜD AG
NAMSA
Element
Eurofins Scientific
Charles River
Sterling Medical Devices
Pacific Biolabs
Toxikon
Steris Laboratories
Europlaz Technologies
Tata Elxsi
Onyx Healthcare
Medical Device Software Validation Segment by Type
Unit Testing
Integration Testing
System Testing
Others
Medical Device Software Validation Segment by Application
Medical Device Manufacturing
Pharmaceutical
Biotechnology
Research and Development
Medical Device Software Validation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Software Validation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Device Software Validation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Software Validation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Medical Device Software Validation companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Unit Testing
- Integration Testing
- System Testing
- Others
Applications
- Medical Device Manufacturing
- Pharmaceutical
- Biotechnology
- Research and Development
Companies covered
- QbD Group
- Intertek
- SGS
- QuEST
- TÜV SÜD AG
- NAMSA
- Element
- Eurofins Scientific
- Charles River
- Sterling Medical Devices
- Pacific Biolabs
- Toxikon
- Steris Laboratories
- Europlaz Technologies
- Tata Elxsi
- Onyx Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Medical Device Software Validation Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Medical Device Software Validation Market Size by Region (2021-2032)
- 1.4.1 Global Medical Device Software Validation Market Size by Region (2021-2026)
- 1.4.2 Global Medical Device Software Validation Market Size by Region (2027-2032)
- 1.5 Key Regions Medical Device Software Validation Market Size (2021-2032)
- 1.5.1 North America Medical Device Software Validation Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Medical Device Software Validation Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Medical Device Software Validation Market Size Growth Rate (2021-2032)
- 1.5.4 South America Medical Device Software Validation Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Medical Device Software Validation Market Size Growth Rate (2021-2032)
2 Medical Device Software Validation Market by Type
- 2.1 Type Introduction
- 2.1.1 Unit Testing
- 2.1.2 Integration Testing
- 2.1.3 System Testing
- 2.1.4 Others
- 2.2 Global Medical Device Software Validation Market Size by Type
- 2.2.1 Global Medical Device Software Validation Market Size Overview by Type (2021-2032)
- 2.2.2 Global Medical Device Software Validation Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Medical Device Software Validation Market Size Forecasted by Type (2027-2032)
- 2.3 Global Medical Device Software Validation Market Size by Regions
- 2.3.1 North America Medical Device Software Validation Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Medical Device Software Validation Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Medical Device Software Validation Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Medical Device Software Validation Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Medical Device Software Validation Market Size Breakdown by Type (2021-2026)
3 Medical Device Software Validation Market by Application
- 3.1 Type Introduction
- 3.1.1 Medical Device Manufacturing
- 3.1.2 Pharmaceutical
- 3.1.3 Biotechnology
- 3.1.4 Research and Development
- 3.2 Global Medical Device Software Validation Market Size by Application
- 3.2.1 Global Medical Device Software Validation Market Size Overview by Application (2021-2032)
- 3.2.2 Global Medical Device Software Validation Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Medical Device Software Validation Market Size Forecasted by Application (2027-2032)
- 3.3 Global Medical Device Software Validation Market Size by Regions
- 3.3.1 North America Medical Device Software Validation Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Medical Device Software Validation Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Medical Device Software Validation Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Medical Device Software Validation Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Medical Device Software Validation Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Medical Device Software Validation Industry Trends
- 4.2 Medical Device Software Validation Industry Drivers
- 4.3 Medical Device Software Validation Industry Opportunities and Challenges
- 4.4 Medical Device Software Validation Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Medical Device Software Validation Revenue (2021-2026)
- 5.2 Global Medical Device Software Validation Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Medical Device Software Validation Key Company Headquarters & Area Served
- 5.4 Global Medical Device Software Validation Company, Product Type & Application
- 5.5 Global Medical Device Software Validation Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Medical Device Software Validation Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Medical Device Software Validation Players Market Share by Revenue in 2025
- 5.6.3 2025 Medical Device Software Validation Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 QbD Group
- 6.1.1 QbD Group Company Information
- 6.1.2 QbD Group Business Overview
- 6.1.3 QbD Group Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 QbD Group Medical Device Software Validation Product Portfolio
- 6.1.5 QbD Group Recent Developments
- 6.2 Intertek
- 6.2.1 Intertek Company Information
- 6.2.2 Intertek Business Overview
- 6.2.3 Intertek Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Intertek Medical Device Software Validation Product Portfolio
- 6.2.5 Intertek Recent Developments
- 6.3 SGS
- 6.3.1 SGS Company Information
- 6.3.2 SGS Business Overview
- 6.3.3 SGS Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 SGS Medical Device Software Validation Product Portfolio
- 6.3.5 SGS Recent Developments
- 6.4 QuEST
- 6.4.1 QuEST Company Information
- 6.4.2 QuEST Business Overview
- 6.4.3 QuEST Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 QuEST Medical Device Software Validation Product Portfolio
- 6.4.5 QuEST Recent Developments
- 6.5 TÜV SÜD AG
- 6.5.1 TÜV SÜD AG Company Information
- 6.5.2 TÜV SÜD AG Business Overview
- 6.5.3 TÜV SÜD AG Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 TÜV SÜD AG Medical Device Software Validation Product Portfolio
- 6.5.5 TÜV SÜD AG Recent Developments
- 6.6 NAMSA
- 6.6.1 NAMSA Company Information
- 6.6.2 NAMSA Business Overview
- 6.6.3 NAMSA Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 NAMSA Medical Device Software Validation Product Portfolio
- 6.6.5 NAMSA Recent Developments
- 6.7 Element
- 6.7.1 Element Company Information
- 6.7.2 Element Business Overview
- 6.7.3 Element Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Element Medical Device Software Validation Product Portfolio
- 6.7.5 Element Recent Developments
- 6.8 Eurofins Scientific
- 6.8.1 Eurofins Scientific Company Information
- 6.8.2 Eurofins Scientific Business Overview
- 6.8.3 Eurofins Scientific Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Eurofins Scientific Medical Device Software Validation Product Portfolio
- 6.8.5 Eurofins Scientific Recent Developments
- 6.9 Charles River
- 6.9.1 Charles River Company Information
- 6.9.2 Charles River Business Overview
- 6.9.3 Charles River Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Charles River Medical Device Software Validation Product Portfolio
- 6.9.5 Charles River Recent Developments
- 6.10 Sterling Medical Devices
- 6.10.1 Sterling Medical Devices Company Information
- 6.10.2 Sterling Medical Devices Business Overview
- 6.10.3 Sterling Medical Devices Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Sterling Medical Devices Medical Device Software Validation Product Portfolio
- 6.10.5 Sterling Medical Devices Recent Developments
- 6.11 Pacific Biolabs
- 6.11.1 Pacific Biolabs Company Information
- 6.11.2 Pacific Biolabs Business Overview
- 6.11.3 Pacific Biolabs Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Pacific Biolabs Medical Device Software Validation Product Portfolio
- 6.11.5 Pacific Biolabs Recent Developments
- 6.12 Toxikon
- 6.12.1 Toxikon Company Information
- 6.12.2 Toxikon Business Overview
- 6.12.3 Toxikon Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Toxikon Medical Device Software Validation Product Portfolio
- 6.12.5 Toxikon Recent Developments
- 6.13 Steris Laboratories
- 6.13.1 Steris Laboratories Company Information
- 6.13.2 Steris Laboratories Business Overview
- 6.13.3 Steris Laboratories Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Steris Laboratories Medical Device Software Validation Product Portfolio
- 6.13.5 Steris Laboratories Recent Developments
- 6.14 Europlaz Technologies
- 6.14.1 Europlaz Technologies Company Information
- 6.14.2 Europlaz Technologies Business Overview
- 6.14.3 Europlaz Technologies Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Europlaz Technologies Medical Device Software Validation Product Portfolio
- 6.14.5 Europlaz Technologies Recent Developments
- 6.15 Tata Elxsi
- 6.15.1 Tata Elxsi Company Information
- 6.15.2 Tata Elxsi Business Overview
- 6.15.3 Tata Elxsi Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Tata Elxsi Medical Device Software Validation Product Portfolio
- 6.15.5 Tata Elxsi Recent Developments
- 6.16 Onyx Healthcare
- 6.16.1 Onyx Healthcare Company Information
- 6.16.2 Onyx Healthcare Business Overview
- 6.16.3 Onyx Healthcare Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Onyx Healthcare Medical Device Software Validation Product Portfolio
- 6.16.5 Onyx Healthcare Recent Developments
7 North America
- 7.1 North America Medical Device Software Validation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Medical Device Software Validation Market Size by Country (2021-2026)
- 7.3 North America Medical Device Software Validation Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Medical Device Software Validation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Medical Device Software Validation Market Size by Country (2021-2026)
- 8.3 Europe Medical Device Software Validation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Device Software Validation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Medical Device Software Validation Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Medical Device Software Validation Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Medical Device Software Validation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Medical Device Software Validation Market Size by Country (2021-2026)
- 10.3 South America Medical Device Software Validation Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Device Software Validation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Medical Device Software Validation Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Medical Device Software Validation Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst